This discrepancy between opposed roles of CD73 may be due to specific changes in endometrial cancers (endometrial epithelial barrier integrity) or may be a consequence of predominant presence of the soluble form of CD73 (sCD73). The gene discussed is NT5E; the disease is endometrial cancer.